202 related articles for article (PubMed ID: 9234931)
21. [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
Cornic M; Guidez F; Delva L; Agadir A; Degos L; Chomienne C
Bull Cancer; 1992; 79(7):697-704. PubMed ID: 1334741
[TBL] [Abstract][Full Text] [Related]
22. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
[TBL] [Abstract][Full Text] [Related]
23. Involvement of retinoic acid receptor alpha in the stimulation of tissue-type plasminogen-activator gene expression in human endothelial cells.
Kooistra T; Lansink M; Arts J; Sitter T; Toet K
Eur J Biochem; 1995 Sep; 232(2):425-32. PubMed ID: 7556191
[TBL] [Abstract][Full Text] [Related]
24. Nicotine modulates the effects of retinoids on growth inhibition and RAR beta expression in lung cancer cells.
Chen GQ; Lin B; Dawson MI; Zhang XK
Int J Cancer; 2002 May; 99(2):171-8. PubMed ID: 11979430
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.
Dhar A; Liu S; Klucik J; Berlin KD; Madler MM; Lu S; Ivey RT; Zacheis D; Brown CW; Nelson EC; Birckbichler PJ; Benbrook DM
J Med Chem; 1999 Sep; 42(18):3602-14. PubMed ID: 10479291
[TBL] [Abstract][Full Text] [Related]
26. Biologically active heteroarotinoids exhibiting anticancer activity and decreased toxicity.
Benbrook DM; Madler MM; Spruce LW; Birckbichler PJ; Nelson EC; Subramanian S; Weerasekare GM; Gale JB; Patterson MK; Wang B; Wang W; Lu S; Rowland TC; DiSivestro P; Lindamood C; Hill DL; Berlin KD
J Med Chem; 1997 Oct; 40(22):3567-83. PubMed ID: 9357524
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
Wan H; Dawson MI; Hong WK; Lotan R
Oncogene; 1997 Oct; 15(17):2109-18. PubMed ID: 9366527
[TBL] [Abstract][Full Text] [Related]
28. Retinoic acid receptor alpha mediates growth inhibition by retinoids in rat pancreatic carcinoma DSL-6A/C1 cells.
Brembeck FH; Kaiser A; Detjen K; Hotz H; Foitzik T; Buhr HJ; Riecken EO; Rosewicz S
Br J Cancer; 1998 Nov; 78(10):1288-95. PubMed ID: 9823968
[TBL] [Abstract][Full Text] [Related]
29. Retinyl methyl ether: binding to transport proteins and effect on transcriptional regulation.
Sani BP; Zhang X; Hill DL; Shealy YF
Biochem Biophys Res Commun; 1996 Jun; 223(2):293-8. PubMed ID: 8670275
[TBL] [Abstract][Full Text] [Related]
30. Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids.
Haugen BR; Larson LL; Pugazhenthi U; Hays WR; Klopper JP; Kramer CA; Sharma V
J Clin Endocrinol Metab; 2004 Jan; 89(1):272-80. PubMed ID: 14715861
[TBL] [Abstract][Full Text] [Related]
31. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids.
Le Q; Dawson MI; Soprano DR; Soprano KJ
Oncogene; 2000 Mar; 19(11):1457-65. PubMed ID: 10723137
[TBL] [Abstract][Full Text] [Related]
32. Keratinocyte-specific retinoid regulation of human cellular retinoic acid binding protein-II (hCRABPII) gene promoter requires an evolutionarily conserved DR1 retinoic acid-responsive element.
Di W; Li XY; Datta S; Aström A; Fisher GJ; Chambon P; Voorhees JJ; Xiao JH
J Invest Dermatol; 1998 Dec; 111(6):1109-15. PubMed ID: 9856825
[TBL] [Abstract][Full Text] [Related]
33. Activation of three distinct RXR/RAR heterodimers induces growth arrest and differentiation of neuroblastoma cells.
Giannini G; Dawson MI; Zhang X; Thiele CJ
J Biol Chem; 1997 Oct; 272(42):26693-701. PubMed ID: 9334253
[TBL] [Abstract][Full Text] [Related]
34. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
Agadir A; Shealy YF; Hill DL; Zhang X
Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
[TBL] [Abstract][Full Text] [Related]
35. A four-amino-acid insertion in the ligand-binding domain inactivates hRXRbeta and renders dominant negative activity.
Mahajna J; Shi B; Bruskin A
DNA Cell Biol; 1997 Apr; 16(4):463-76. PubMed ID: 9150434
[TBL] [Abstract][Full Text] [Related]
36. Melanoma cell growth inhibition and melanocortin receptor downregulation induced by selective and non-selective retinoids.
Siegrist W; Hintermann E; Roggo CN; Apfel CM; Klaus M; Eberle AN
Melanoma Res; 1998 Apr; 8(2):113-22. PubMed ID: 9610863
[TBL] [Abstract][Full Text] [Related]
37. Constitutively active retinoid receptors exhibit interfamily and intrafamily promoter specificity.
Underhill TM; Cash DE; Linney E
Mol Endocrinol; 1994 Mar; 8(3):274-85. PubMed ID: 8015546
[TBL] [Abstract][Full Text] [Related]
38. A novel function of differentiation revealed by cDNA microarray profiling of p75NTR-regulated gene expression.
Nalbandian A; Pang AL; Rennert OM; Chan WY; Ravindranath N; Djakiew D
Differentiation; 2005 Oct; 73(8):385-96. PubMed ID: 16316409
[TBL] [Abstract][Full Text] [Related]
39. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.
Lee HY; Dawson MI; Walsh GL; Nesbitt JC; Eckert RL; Fuchs E; Hong WK; Lotan R; Kurie JM
Cell Growth Differ; 1996 Aug; 7(8):997-1004. PubMed ID: 8853895
[TBL] [Abstract][Full Text] [Related]
40. Retinoid pathway and cancer therapeutics.
Bushue N; Wan YJ
Adv Drug Deliv Rev; 2010 Oct; 62(13):1285-98. PubMed ID: 20654663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
